معرفی
Dr. Susannah Walsh is an Associate Professor in Microbiology and Associate Head at the Leicester School of Pharmacy, De Montfort University, within the Faculty of Health and Life Sciences. Her work bridges academic leadership, microbiology research, and infection control innovation. She is actively involved in research, teaching, and national advisory roles.
- PhD, BSc, MBA
- Member of Society for Applied Microbiology, Hospital Infection Society, American Society for Microbiology
- Editor, Journal of Applied Microbiology and Letters in Applied Microbiology (2004–2007)
Dr. Walsh's research centers on infection prevention and control, with key interests in disinfection, sterilization, antimicrobial resistance, and novel catalyst systems. She investigates the mode of action of biocides, develops new antimicrobial technologies (including patented catalysts), evaluates antimicrobial fabrics, and assesses travel hand rub efficacy. Her interdisciplinary collaborations span pharmacy, textile engineering, and public health.
Her recent publications reflect a strong trend in antimicrobial innovation, particularly in catalytic disinfection systems, environmental microbiology, and clinical decontamination methods. Themes include hydrogen peroxide activation, sporicidal activity, antibacterial textiles, and antibiotic resistance in urban environments.
- Society for Applied Microbiology Students into Work Grant (2014, 2011, 2008, 2006)
- Hospital Infection Society Small Research Grant (2008–2009, 2002–present)
Dr. Walsh supervises multiple PhD students and has led numerous funded research projects with institutions and industry partners such as DSTL, Reckitt Benckiser, Molnlycke Health Care, and Better Vision Solutions. She has been principal or co-investigator on grants exceeding £70,000 and has contributed to commercialization efforts for novel antimicrobial technologies. She also leads randomized controlled trials on surgical and body hygiene practices. Her laboratory work is supported by internal and external funding, including HEIF and Framework 7 projects. She is affiliated with the Leicester Institute for Pharmaceutical Innovation and the Infectious Disease Research Group.
